Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akihiro Deguchi

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
International Journal of Oncology|January 1, 2014
Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivoHisaaki Miyoshi, Kiyohito Kato, Hisakazu Iwama, et al.
International Journal of Oncology|May 9, 2014
Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivoHisaaki Miyoshi, Kiyohito Kato, Hisakazu Iwama, et al.
Oncology|December 20, 2017
Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter StudyChikara Ogawa, Masahiro Morita, Akina Omura, et al.
Cancers|October 14, 2022
The Clinical Impact of Hepatic Arterial Infusion Chemotherapy New-FP for Hepatocellular Carcinoma with Preserved Liver FunctionHideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu, et al.
International Journal of Oncology|November 21, 2008
Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinomaHamdy Saad Mohammad, Kazutaka Kurokohchi, Hirohito Yoneyama, et al.
Journal of Gastroenterology|May 10, 2018
Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in JapanHidenori Toyoda, Masanori Atsukawa, Koichi Takaguchi, et al.
JCO Clinical Cancer Informatics|May 12, 2025
Prognostic Significance of the BALAD Serological Model in Systemic Therapies for Hepatocellular Carcinoma: A Personalized Approach to the Prediction of Survival BenefitHidenori Toyoda, Atsushi Hiraoka, Hironori Ochi, et al.
Cancers|February 10, 2021
Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular CarcinomaHideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
International Journal of Oncology|January 1, 2014
Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivoHisaaki Miyoshi, Kiyohito Kato, Hisakazu Iwama, et al.
International Journal of Oncology|May 9, 2014
Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivoHisaaki Miyoshi, Kiyohito Kato, Hisakazu Iwama, et al.
Oncology|December 20, 2017
Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter StudyChikara Ogawa, Masahiro Morita, Akina Omura, et al.
Cancers|October 14, 2022
The Clinical Impact of Hepatic Arterial Infusion Chemotherapy New-FP for Hepatocellular Carcinoma with Preserved Liver FunctionHideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu, et al.
International Journal of Oncology|November 21, 2008
Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinomaHamdy Saad Mohammad, Kazutaka Kurokohchi, Hirohito Yoneyama, et al.
Journal of Gastroenterology|May 10, 2018
Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in JapanHidenori Toyoda, Masanori Atsukawa, Koichi Takaguchi, et al.
JCO Clinical Cancer Informatics|May 12, 2025
Prognostic Significance of the BALAD Serological Model in Systemic Therapies for Hepatocellular Carcinoma: A Personalized Approach to the Prediction of Survival BenefitHidenori Toyoda, Atsushi Hiraoka, Hironori Ochi, et al.
Cancers|February 10, 2021
Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular CarcinomaHideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu, et al.
Pageof 6